CVAC
Price
$4.10
Change
-$0.08 (-1.91%)
Updated
Jan 17 closing price
Capitalization
919.79M
94 days until earnings call
MDGL
Price
$293.64
Change
+$20.85 (+7.64%)
Updated
Jan 17 closing price
Capitalization
6.4B
38 days until earnings call
Ad is loading...

CVAC vs MDGL

Header iconCVAC vs MDGL Comparison
Open Charts CVAC vs MDGLBanner chart's image
CureVac
Price$4.10
Change-$0.08 (-1.91%)
Volume$590.8K
Capitalization919.79M
Madrigal Pharmaceuticals
Price$293.64
Change+$20.85 (+7.64%)
Volume$866.12K
Capitalization6.4B
CVAC vs MDGL Comparison Chart
Loading...
CVAC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MDGL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CVAC vs. MDGL commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CVAC is a Hold and MDGL is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 19, 2025
Stock price -- (CVAC: $4.10 vs. MDGL: $293.64)
Brand notoriety: CVAC and MDGL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CVAC: 68% vs. MDGL: 221%
Market capitalization -- CVAC: $919.79M vs. MDGL: $6.4B
CVAC [@Biotechnology] is valued at $919.79M. MDGL’s [@Biotechnology] market capitalization is $6.4B. The market cap for tickers in the [@Biotechnology] industry ranges from $368.92B to $0. The average market capitalization across the [@Biotechnology] industry is $2.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CVAC’s FA Score shows that 1 FA rating(s) are green whileMDGL’s FA Score has 1 green FA rating(s).

  • CVAC’s FA Score: 1 green, 4 red.
  • MDGL’s FA Score: 1 green, 4 red.
According to our system of comparison, CVAC is a better buy in the long-term than MDGL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CVAC’s TA Score shows that 3 TA indicator(s) are bullish while MDGL’s TA Score has 3 bullish TA indicator(s).

  • CVAC’s TA Score: 3 bullish, 3 bearish.
  • MDGL’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, CVAC is a better buy in the short-term than MDGL.

Price Growth

CVAC (@Biotechnology) experienced а -2.61% price change this week, while MDGL (@Biotechnology) price change was -13.36% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.44%. For the same industry, the average monthly price growth was +2.66%, and the average quarterly price growth was -1.92%.

Reported Earning Dates

CVAC is expected to report earnings on May 21, 2025.

MDGL is expected to report earnings on May 13, 2025.

Industries' Descriptions

@Biotechnology (-1.44% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MDGL($6.4B) has a higher market cap than CVAC($920M). CVAC YTD gains are higher at: 20.235 vs. MDGL (-4.838). CVAC has higher annual earnings (EBITDA): 166M vs. MDGL (-502.65M). MDGL has more cash in the bank: 999M vs. CVAC (555M). CVAC has less debt than MDGL: CVAC (40.1M) vs MDGL (119M). CVAC has higher revenues than MDGL: CVAC (543M) vs MDGL (76.8M).
CVACMDGLCVAC / MDGL
Capitalization920M6.4B14%
EBITDA166M-502.65M-33%
Gain YTD20.235-4.838-418%
P/E Ratio8.47N/A-
Revenue543M76.8M707%
Total Cash555M999M56%
Total Debt40.1M119M34%
FUNDAMENTALS RATINGS
MDGL: Fundamental Ratings
MDGL
OUTLOOK RATING
1..100
32
VALUATION
overvalued / fair valued / undervalued
1..100
68
Overvalued
PROFIT vs RISK RATING
1..100
30
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
42
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CVACMDGL
RSI
ODDS (%)
Bearish Trend 12 days ago
84%
Bearish Trend 12 days ago
73%
Stochastic
ODDS (%)
Bearish Trend 12 days ago
90%
Bearish Trend 12 days ago
90%
Momentum
ODDS (%)
Bullish Trend 12 days ago
78%
Bullish Trend 12 days ago
76%
MACD
ODDS (%)
Bullish Trend 12 days ago
78%
Bullish Trend 12 days ago
81%
TrendWeek
ODDS (%)
Bullish Trend 12 days ago
77%
Bullish Trend 12 days ago
76%
TrendMonth
ODDS (%)
Bullish Trend 12 days ago
70%
Bullish Trend 12 days ago
76%
Advances
ODDS (%)
Bullish Trend 13 days ago
77%
Bullish Trend 12 days ago
78%
Declines
ODDS (%)
N/A
Bearish Trend 20 days ago
81%
BollingerBands
ODDS (%)
Bearish Trend 12 days ago
90%
Bearish Trend 12 days ago
71%
Aroon
ODDS (%)
N/A
Bearish Trend 12 days ago
79%
View a ticker or compare two or three
Ad is loading...
CVAC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MDGL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
XMMO129.690.58
+0.45%
Invesco S&P MidCap Momentum ETF
LGOV20.810.04
+0.19%
First Trust Long Duration Opp ETF
SIO25.460.04
+0.17%
Touchstone Strategic Income ETF
FLSW32.740.03
+0.09%
Franklin FTSE Switzerland ETF
JHDV35.26N/A
N/A
JHancock U.S. High Dividend ETF

CVAC and

Correlation & Price change

A.I.dvisor indicates that over the last year, CVAC has been loosely correlated with BNTX. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if CVAC jumps, then BNTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CVAC
1D Price
Change %
CVAC100%
-1.91%
BNTX - CVAC
44%
Loosely correlated
-0.74%
MRNA - CVAC
44%
Loosely correlated
+0.89%
ARCT - CVAC
42%
Loosely correlated
-1.29%
MDGL - CVAC
42%
Loosely correlated
+7.64%
AXON - CVAC
39%
Loosely correlated
+1.37%
More